JP2012518415A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518415A5
JP2012518415A5 JP2011551266A JP2011551266A JP2012518415A5 JP 2012518415 A5 JP2012518415 A5 JP 2012518415A5 JP 2011551266 A JP2011551266 A JP 2011551266A JP 2011551266 A JP2011551266 A JP 2011551266A JP 2012518415 A5 JP2012518415 A5 JP 2012518415A5
Authority
JP
Japan
Prior art keywords
cells
item
pluripotent stem
stem cells
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011551266A
Other languages
English (en)
Japanese (ja)
Other versions
JP6189581B2 (ja
JP2012518415A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/024881 external-priority patent/WO2010096746A1/en
Publication of JP2012518415A publication Critical patent/JP2012518415A/ja
Publication of JP2012518415A5 publication Critical patent/JP2012518415A5/ja
Application granted granted Critical
Publication of JP6189581B2 publication Critical patent/JP6189581B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011551266A 2009-02-20 2010-02-22 幹細胞の分化のための方法および組成物 Active JP6189581B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15421009P 2009-02-20 2009-02-20
US61/154,210 2009-02-20
PCT/US2010/024881 WO2010096746A1 (en) 2009-02-20 2010-02-22 Methods and compositions for the differentiation of stem cells

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2015213836A Division JP2016019543A (ja) 2009-02-20 2015-10-30 幹細胞の分化のための方法および組成物
JP2017113273A Division JP6691509B2 (ja) 2009-02-20 2017-06-08 幹細胞の分化のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2012518415A JP2012518415A (ja) 2012-08-16
JP2012518415A5 true JP2012518415A5 (enExample) 2013-04-04
JP6189581B2 JP6189581B2 (ja) 2017-08-30

Family

ID=42101531

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011551266A Active JP6189581B2 (ja) 2009-02-20 2010-02-22 幹細胞の分化のための方法および組成物
JP2015213836A Pending JP2016019543A (ja) 2009-02-20 2015-10-30 幹細胞の分化のための方法および組成物
JP2017113273A Active JP6691509B2 (ja) 2009-02-20 2017-06-08 幹細胞の分化のための方法および組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015213836A Pending JP2016019543A (ja) 2009-02-20 2015-10-30 幹細胞の分化のための方法および組成物
JP2017113273A Active JP6691509B2 (ja) 2009-02-20 2017-06-08 幹細胞の分化のための方法および組成物

Country Status (5)

Country Link
US (1) US8557580B2 (enExample)
EP (1) EP2398897B1 (enExample)
JP (3) JP6189581B2 (enExample)
CA (1) CA2753208C (enExample)
WO (1) WO2010096746A1 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2203176B1 (en) 2007-09-28 2014-11-26 Anthrogenesis Corporation Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
AU2010236632A1 (en) * 2009-04-13 2011-09-15 The Regents Of The University Of California Methods and compositions for stem cell cultures
EP2539437B1 (en) 2010-02-25 2017-08-02 The Johns Hopkins University SMOOTH MUSCLE-LIKE CELLS (SMLCs) DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
AU2011250651B2 (en) * 2010-05-05 2015-10-08 Genea Ip Holdings Pty Limited Media and methods for cell culture
US20120064040A1 (en) * 2010-06-03 2012-03-15 The Regents Of The University Of California Serum free culture medium and supplement
MX342995B (es) 2010-07-13 2016-10-21 Anthrogenesis Corp Métodos de generar células asesinas naturales.
EP2601289B1 (en) 2010-08-04 2017-07-12 Cellular Dynamics International, Inc. Reprogramming immortalized b cells
JP5597904B2 (ja) * 2010-09-10 2014-10-01 国立大学法人 東京大学 多能性幹細胞からの血液細胞分化に関する培養方法
CN103201377A (zh) 2010-11-09 2013-07-10 隆萨科隆有限公司 控制细胞与基质结合的方法
AU2011329002C1 (en) 2010-11-15 2017-05-25 Accelerated Biosciences Corp. Generation of neural stem cells from human trophoblast stem cells
US20140045265A1 (en) * 2011-02-16 2014-02-13 Salk Institute For Biological Studies Robust and efficient differentiation of human pluripotent stem cells to multipotent vascular progenitors
WO2012115276A1 (en) 2011-02-23 2012-08-30 Kyoto University Method for producing dendritic cells from pluripotent stem cells
WO2012141571A1 (en) * 2011-04-11 2012-10-18 M Abdullah Jaffar Ali Bin Protein-free culture media products
LT2761065T (lt) * 2011-09-29 2018-01-10 Cellsnap, Llc Kompozicijos ir būdai toksigeniškumo testavimui
US10428309B2 (en) 2011-12-01 2019-10-01 New York Stem Cell Foundation, Inc. Systems and methods for producing stem cells and differentiated cells
WO2013082509A1 (en) * 2011-12-01 2013-06-06 The New York Stem Cell Foundation Automated system for producing induced pluripotent stem cells or differentiated cells
US9428732B2 (en) 2011-12-05 2016-08-30 Primorigen Biosciences, Inc. Compositions and methods for differentiating pluripotent stem cells into primitive blood cells and uses thereof
EP2820123B1 (en) * 2012-02-29 2017-10-11 The Johns Hopkins University Method for guiding the derivation of endothelial cells from human pluripotent stem cells employing two-dimensional, feeder-free differentiation
EP2922866B1 (en) 2012-11-21 2019-01-23 Merz Pharma GmbH & Co. KGaA Means and methods for determination of botulinum neurotoxin biological activity
EP2925860B8 (en) 2012-11-30 2019-12-25 Accelerated BioSciences Corp. Methods of differentiating stem cells by modulating mir-124
CA2896053A1 (en) 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Methods for production of platelets from pluripotent stem cells and compositions thereof
EP3622960A1 (en) 2013-02-05 2020-03-18 Celularity, Inc. Natural killer cells from placenta
US9994825B2 (en) 2013-03-15 2018-06-12 The Johns Hopkins University Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix
ES2602078T3 (es) 2013-03-15 2017-02-17 Lonza Cologne Gmbh Composiciones y métodos para mejorar el potencial terapéutico de las células madre
US9506037B2 (en) 2013-03-15 2016-11-29 The Johns Hopkins University Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix
US11976110B2 (en) 2013-06-28 2024-05-07 Merz Pharma Gmbh & Co. Kgaa Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells
US10959997B2 (en) 2013-12-27 2021-03-30 Kyoto Prefectural Public University Corporation Combined agent for cell therapy of corneal endothelial cell
US11352606B2 (en) * 2014-02-10 2022-06-07 The Johns Hopkins University Low oxygen tension enhances endothelial fate of human pluripotent stem cells
US10921312B2 (en) 2014-02-19 2021-02-16 Merz Pharma Gmbh & Co. Kgaa Gangliosides for standardizing and increasing the sensitivity of cells to botulinum neurotoxins in in vitro test systems
KR20160145186A (ko) 2014-04-24 2016-12-19 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 입양 세포 요법 생성물을 생성하기 위한 유도 만능 줄기 세포의 응용
GB2548059B (en) 2014-11-26 2020-09-02 Accelerated Biosciences Corp Induced hepatocytes and uses thereof
KR102514666B1 (ko) 2014-12-19 2023-03-27 메르츠 파마 게엠베하 운트 코. 카가아 세포에서 BoNT/E의 생물학적 활성의 결정을 위한 수단 및 방법
US10626372B1 (en) * 2015-01-26 2020-04-21 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
TWI704156B (zh) 2015-03-04 2020-09-11 德商曼茲法瑪股份有限公司 用於增進肉毒桿菌神經毒素進入細胞之特定攝取的方法
CN122146606A (zh) 2015-11-04 2026-06-05 菲特治疗公司 用于诱导造血细胞分化的方法和组合物
US12642852B1 (en) 2015-11-04 2026-06-02 Fate Therapeutics, Inc. Genomic engineering of pluripotent cells
EP3690022B1 (en) 2016-05-18 2026-03-18 Keio University Cell culture medium for culturing organoid, culture method, and organoid
CA3087344A1 (en) 2018-01-05 2019-07-11 Platelet Biogenesis, Inc. Compositions and methods for producing megakaryocytes
JP2021529770A (ja) 2018-06-29 2021-11-04 プレートレット バイオジェネシス， インコーポレイテッド 薬物送達のための組成物およびその使用方法
EP3847243A1 (en) * 2018-09-07 2021-07-14 Wisconsin Alumni Research Foundation Generation of hematopoietic progenitor cells from human pluripotent stem cells
CN110438065B (zh) * 2019-07-25 2020-06-05 中山大学 一种诱导人诱导性多能干细胞分化为内皮祖细胞的方法
WO2021097346A1 (en) * 2019-11-14 2021-05-20 Amgen Inc. Hematopoietic precursor cell production
JPWO2022039250A1 (enExample) * 2020-08-21 2022-02-24
WO2024018018A1 (fr) 2022-07-21 2024-01-25 Etablissement Francais Du Sang Utilisation d'un composé vitisine pour la production de cellules hématopoïétiques
WO2025126208A1 (en) * 2023-12-12 2025-06-19 Accellta Ltd. Media for maintaining, differentiating, or both, pluripotent stem cells

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3065499D1 (en) 1979-04-11 1983-12-15 Mitsui Petrochemical Ind Process for producing spherical carrier particles for olefin polymerisation catalyst, catalyst comprising such carrier particles, and use of such catalyst in olefin polymerisation
GB9807935D0 (en) 1998-04-14 1998-06-10 Univ Edinburgh Lineage specific cells and progenitor cells
JP2001508302A (ja) 1997-01-10 2001-06-26 ライフ テクノロジーズ，インコーポレイテッド 胚性幹細胞血清置換
EP1163910B1 (en) 1999-03-25 2007-09-26 Mitsubishi Pharma Corporation Rho kinase inhibitors for the prevention or treatment of interstitial pneumonia and pulmonary fibrosis
WO2000078351A1 (en) 1999-06-18 2000-12-28 Mitsubishi Pharma Corporation Osteogenesis promoters
JP4563573B2 (ja) * 2000-12-07 2010-10-13 株式会社カネカ 抗原およびこの抗原を識別するモノクローナル抗体
CA2473910C (en) 2002-01-23 2011-03-15 Bayer Pharmaceuticals Corporation Pyrimidine derivatives as rho-kinase inhibitors
US6664266B2 (en) 2002-03-14 2003-12-16 Children's Medical Center Corporation Axon regeneration with PKC inhibitiors
GB0206860D0 (en) 2002-03-22 2002-05-01 Glaxo Group Ltd Compounds
JP2005523326A (ja) 2002-04-22 2005-08-04 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ プロテインキナーゼｃのペプチドインヒビター
US7427603B2 (en) 2002-09-26 2008-09-23 The Children's Medical Center Corporation Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
BRPI0514641A (pt) 2004-09-08 2008-06-17 Wisconsin Alumni Res Found cultivação das células tronco embriÈnica humana
BRPI0514778B1 (pt) 2004-09-08 2018-07-10 Wisconsin Alumni Research Foundation Meio para cultivar células tronco embrionárias
NZ554866A (en) 2004-11-01 2010-12-24 Wisconsin Alumni Res Found Platelets from stem cells
WO2008011176A2 (en) 2006-07-21 2008-01-24 Northwestern University Myosin light chain kinase inhibitor compounds, compositions and related methods of use
JP2008099662A (ja) * 2006-09-22 2008-05-01 Institute Of Physical & Chemical Research 幹細胞の培養方法
SE0950586L (sv) * 2007-01-17 2009-08-13 Wisconsin Alumni Res Found Förbättrad odling av stamceller
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
JP2008307007A (ja) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
AU2008272949B2 (en) 2007-06-29 2014-05-15 FUJIFILM Cellular Dynamics, Inc. Automated method and apparatus for embryonic stem cell culture
EP2291511B1 (en) * 2008-05-02 2017-06-21 Cellular Dynamics International, Inc. Method for production of mast cells from stem cells

Similar Documents

Publication Publication Date Title
US12606798B2 (en) Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions
JP6691509B2 (ja) 幹細胞の分化のための方法および組成物
CN105026551B (zh) 用于hUTC生长的营养富集培养基
US10100282B2 (en) Differentiation of pluripotent cells
JP2017148079A5 (enExample)
KR100986149B1 (ko) 저 산소 배양액 조건을 이용한 배아 줄기 세포로부터유래된 배상체로부터 혈관 내피 전구 세포의 분화방법
CN114174493A (zh) 使用带电表面从诱导多能干细胞产生多个谱系的方法
CN112553147B (zh) 一种促进肌肉干细胞增殖的生长因子组合物及其应用
CA3219496A1 (en) A method for producing blood progenitor and progenitor t cells, resulting cells and methods and uses thereof
CN110607277B (zh) 一种人类多能干细胞分化巨噬细胞的方法
CN109475582A (zh) 基因递送的改进方法
CN101684454B (zh) 一种定型内胚层细胞的制备和分离方法
TWI860972B (zh) 造血前驅細胞標記
CN120173879A (zh) 一种由多能干细胞向造血干祖细胞分化的培养基组合物、其使用方法和应用
CN115896030A (zh) 诱导胚胎干细胞高效分化为巨核细胞的方法
Wolfe The effect of shear stress on pluripotent stem cells
Johnson Extracellular matrix improves mesenchymal stem cell growth and maintenance of stemness in serum free medium